351 related articles for article (PubMed ID: 31534187)
1. ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts.
Sung JS; Kang CW; Kang S; Jang Y; Chae YC; Kim BG; Cho NH
Oncogene; 2020 Jan; 39(3):664-676. PubMed ID: 31534187
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy.
Broad RV; Jones SJ; Teske MC; Wastall LM; Hanby AM; Thorne JL; Hughes TA
Br J Cancer; 2021 Mar; 124(6):1110-1120. PubMed ID: 33398063
[TBL] [Abstract][Full Text] [Related]
3. Exosome-transmitted FOSL1 from cancer-associated fibroblasts drives colorectal cancer stemness and chemo-resistance through transcriptionally activating ITGB4.
Lin S; Zhu B
Mol Cell Biochem; 2024 Mar; 479(3):665-677. PubMed ID: 37160555
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of FGF9 and NOVA1 in cancer-associated fibroblasts promotes cell proliferation, invasion and migration of triple negative breast cancer.
Zhang B; Liu Y; Yu J; Lin X
Drug Dev Res; 2024 May; 85(3):e22185. PubMed ID: 38657094
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts induce an aggressive phenotypic shift in non-malignant breast epithelial cells via interleukin-8 and S100A8.
Lim H; Koh M; Jin H; Bae M; Lee SY; Kim KM; Jung J; Kim HJ; Park SY; Kim HS; Moon WK; Hwang S; Cho NH; Moon A
J Cell Physiol; 2021 Oct; 236(10):7014-7032. PubMed ID: 33748944
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
[TBL] [Abstract][Full Text] [Related]
8. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
9. Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ß1 secretion.
Ren Y; Jia HH; Xu YQ; Zhou X; Zhao XH; Wang YF; Song X; Zhu ZY; Sun T; Dou Y; Tian WP; Zhao XL; Kang CS; Mei M
Mol Cancer; 2018 Jan; 17(1):5. PubMed ID: 29325547
[TBL] [Abstract][Full Text] [Related]
10. Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells.
Bierie B; Pierce SE; Kroeger C; Stover DG; Pattabiraman DR; Thiru P; Liu Donaher J; Reinhardt F; Chaffer CL; Keckesova Z; Weinberg RA
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2337-E2346. PubMed ID: 28270621
[TBL] [Abstract][Full Text] [Related]
11. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
[TBL] [Abstract][Full Text] [Related]
12. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
Liu J; Li P; Wang L; Li M; Ge Z; Noordam L; Lieshout R; Verstegen MMA; Ma B; Su J; Yang Q; Zhang R; Zhou G; Carrascosa LC; Sprengers D; IJzermans JNM; Smits R; Kwekkeboom J; van der Laan LJW; Peppelenbosch MP; Pan Q; Cao W
Cell Mol Gastroenterol Hepatol; 2021; 11(2):407-431. PubMed ID: 32932015
[TBL] [Abstract][Full Text] [Related]
13. Stromal Fibroblasts from the Interface Zone of Triple Negative Breast Carcinomas Induced Epithelial-Mesenchymal Transition and its Inhibition by Emodin.
Hsu HC; Liu LC; Wang HY; Hung CM; Lin YC; Ho CT; Way TD
PLoS One; 2017; 12(1):e0164661. PubMed ID: 28060811
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
[TBL] [Abstract][Full Text] [Related]
15. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.
Chen B; Sang Y; Song X; Zhang D; Wang L; Zhao W; Liang Y; Zhang N; Yang Q
Theranostics; 2021; 11(8):3932-3947. PubMed ID: 33664871
[TBL] [Abstract][Full Text] [Related]
16. Melanoma-derived exosomes induce reprogramming fibroblasts into cancer-associated fibroblasts via Gm26809 delivery.
Hu T; Hu J
Cell Cycle; 2019 Nov; 18(22):3085-3094. PubMed ID: 31544590
[TBL] [Abstract][Full Text] [Related]
17. Aberrant low expression of p85α in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b.
Chen Y; Zeng C; Zhan Y; Wang H; Jiang X; Li W
Oncogene; 2017 Aug; 36(33):4692-4705. PubMed ID: 28394344
[TBL] [Abstract][Full Text] [Related]
18. Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.
Baroni S; Romero-Cordoba S; Plantamura I; Dugo M; D'Ippolito E; Cataldo A; Cosentino G; Angeloni V; Rossini A; Daidone MG; Iorio MV
Cell Death Dis; 2016 Jul; 7(7):e2312. PubMed ID: 27468688
[TBL] [Abstract][Full Text] [Related]
19. Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.
Kikuchi K; McNamara KM; Miki Y; Moon JY; Choi MH; Omata F; Sakurai M; Onodera Y; Rai Y; Ohi Y; Sagara Y; Miyashita M; Ishida T; Ohuchi N; Sasano H
Breast Cancer Res Treat; 2017 Dec; 166(3):709-723. PubMed ID: 28831645
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling.
Wen S; Hou Y; Fu L; Xi L; Yang D; Zhao M; Qin Y; Sun K; Teng Y; Liu M
Cancer Lett; 2019 Feb; 442():320-332. PubMed ID: 30391782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]